Nvidia failed to satisfy investors’ lofty expectations for the $3 trillion chipmaker’s fiscal year 2025 second-quarter earnings report, sending the stock lower and slightly weighing on the tech-heavy Nasdaq Composite Index.
Company shares tumbled 6 percent during the Aug. 29 trading session, sliding below $118. The Nasdaq was little changed, dipping 0.23 percent. Both moderately recovered in the trading session on Friday.
While the stock is still up 144 percent year-to-date, market watchers who spoke with The Epoch Times say that traders might think tiny cracks are beginning to emerge at Nvidia.
Armchair and institutional investors paid close attention to Nvidia’s earnings report after the midweek closing bell. The company is at the center of the enormous artificial intelligence boom that has swept Wall Street over the last two years. […]
— Read More: www.theepochtimes.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
